Shinde, S. (2023) “Overview on remogliflozin SGLT-2 inhibitor in the management of type-2 diabetic mellitus in human beings”, Fundamental and Experimental Biology, 112(4), pp. 156–167. doi: 10.31489/2023bmg4/156-167.